EUVIMEDEUVIMED entdecken
Open Access

Vitamin‐B6 Pretreated Bovine Pericardial Bioprosthetic Heart Valve Leaflets Demonstrate Reduced Platelet Adhesion and Activation

Nikia T Toomey, Tina E Thomas, Emily J Hall, Chandrasekaran Nagaswami, Ivan Alferiev, Jonathan M Chen, Giovanni Ferrari, Stanley J Stachelek, Robert J Levy iD

Journal of Biomedical Materials Research Part A · 2026

DOI: 10.1002/jbma.70020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, 2026. Verfasst von Nikia T Toomey und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Pediatrics, The Topolewski Pediatric Heart Valve Center, The Children's Hospital of Philadelphia, Philadelphia,…. Hauptthemen laut MEDLINE: Platelet Adhesiveness, Heart Valve Prosthesis, Bioprosthesis, Platelet Activation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Erin's Fund, The William J Rashkind Endowment.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bioprosthetic heart valves (BHV) fabricated from heterograft tissue such as glutaraldehyde fixed bovine pericardium (BP), while less thrombogenic than mechanical valve prostheses, nevertheless demonstrate a significant risk for platelet initiated thromboembolic events. We showed previously using in vitro and in vivo model systems that pyridoxamine (PYR), a Vitamin B6 vitamer, used as a BP pretreatment, mitigated advanced glycation end product (AGE) formation. PYR is also known to inhibit platelet aggregation. In the present studies, both BP and collagen‐coated polyvinyl chloride tubing (PVC‐collagen) were fixed with glutaraldehyde and were either untreated or pretreated with PYR; both the PYR content and binding stability were quantitated. PYR‐BP binding stability was demonstrated in vitro over 28 days. Methylglyoxal (MGO), a representative AGE, was used to modify BP and PVC‐collagen for use in platelet activation studies in an ex vivo flow loop with human whole blood. MGO modified collagen‐coated PVC demonstrated both increased platelet activation, per P‐selectin expression, and increased platelet adhesion compared to non‐MGO modified samples. PYR pretreatment of either collagen‐coated PVC or BP, with or without MGO exposure, significantly mitigated these effects. In conclusion, BP and collagen surfaces are susceptible to platelet activation and adhesion that is effectively mitigated by vitamin B6.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet AdhesivenessHeart Valve ProsthesisBioprosthesisPlatelet ActivationPericardiumVitamin B 6AnimalsCattleHumansCollagenPyridoxamineBlood PlateletsPolyvinyl Chloride

Stichwörter der Autor:innen

advanced glycation end productbioprosthetic heart valvesplateletspyridoxamine

Substanzen

Vitamin B 6CollagenPyridoxaminePolyvinyl Chloride

Autor:innen und Institutionen

  • Division of Cardiology, Department of Pediatrics, The Topolewski Pediatric Heart Valve Center, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Department of Bioengineering, School of Engineering and Applied Science, The University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Cell and Developmental Biology, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Perelman School of Medicine, the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Division of Pediatric Cardiac Surgery, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Department of Surgery, Columbia University, New York, New York, USA.

ORCID-Profile: Robert J Levy

Förderung

  • NHLBI NIH HHS
  • Erin's Fund
  • The William J Rashkind Endowment
  • The Kibel Fund for Aortic Valve Research
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Toomey, N. T., Thomas, T. E., Hall, E. J., Nagaswami, C., Alferiev, I., Chen, J. M., Ferrari, G., Stachelek, S. J., & Levy, R. J. (2026). Vitamin‐B6 Pretreated Bovine Pericardial Bioprosthetic Heart Valve Leaflets Demonstrate Reduced Platelet Adhesion and Activation. Journal of Biomedical Materials Research Part A. https://doi.org/10.1002/jbma.70020

Vancouver

Toomey NT, Thomas TE, Hall EJ, Nagaswami C, Alferiev I, Chen JM, et al. Vitamin‐B6 Pretreated Bovine Pericardial Bioprosthetic Heart Valve Leaflets Demonstrate Reduced Platelet Adhesion and Activation. Journal of Biomedical Materials Research Part A. 2026. doi:10.1002/jbma.70020

BibTeX
@article{Toomey2026,
  author = {Toomey, Nikia T and Thomas, Tina E and Hall, Emily J and Nagaswami, Chandrasekaran and Alferiev, Ivan and Chen, Jonathan M and Ferrari, Giovanni and Stachelek, Stanley J and Levy, Robert J},
  title = {Vitamin‐B6 Pretreated Bovine Pericardial Bioprosthetic Heart Valve Leaflets Demonstrate Reduced Platelet Adhesion and Activation},
  journal = {Journal of Biomedical Materials Research Part A},
  year = {2026},
  doi = {10.1002/jbma.70020}
}
Kostenlos starten →